share_log

Lifeist Announces Reorganization of the Board of Directors

Lifeist Announces Reorganization of the Board of Directors

Lifeist宣佈董事會重組
GlobeNewswire ·  2024/12/14 06:00

TORONTO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to support wellness in innovative ways, today announced a reorganization of its Board of Directors. As part of Lifeist's ongoing efforts to enhance corporate governance and further strengthen its leadership structure, Meni Morim, a director of the Company and the former CEO of the Company, has been appointed Chairman of the Board, while Branden Spikes, a director of the Company, has transitioned to the role of Lead Independent Director.

多倫多,2024年12月13日(環球新聞)—— Lifeist Wellness Inc.("Lifeist" 或 "公司")(TSXV: LFST)(法蘭克福: M5B0)(OTCMKTS: LFSWF)是一家利用科技和科學進步以創新方式支持健康的健康科技公司,今天宣佈對其董事會進行重組。作爲Lifeist持續增強公司治理和進一步強化領導結構的努力的一部分,公司的董事、前首席執行官Meni Morim被任命爲董事會主席,而公司的董事Branden Spikes則轉任爲首席獨立董事。

Meni Morim, who has been the driving force behind Lifeist's transformation and successful realignment of the Company's business strategy, assumes the role of Chairman. In this capacity, Meni will continue to provide strategic guidance to Lifeist's executive team and Board, ensuring the successful execution of the Company's long-term vision.

Meni Morim一直是推動Lifeist轉型和成功重組公司業務策略的主要力量,擔任董事會主席。在此職位上,Meni將繼續爲Lifeist的執行團隊和董事會提供戰略指導,確保公司長期願景的成功執行。

Branden Spikes, who served as Chairman of the Board since 2019, and has been instrumental in guiding the Company's strategic direction, takes on the role of Lead Independent Director to act as the effective leader of the Board and to ensure that the Board's agenda will enable it to successfully carry out its duties. In this role, Branden will continue to play a critical role in overseeing the Board's discharge of its duties together with the Chairman, corporate governance, strategic initiatives, and Lifeist's operations while providing valuable independent oversight of the Company's management.

Branden Spikes自2019年起擔任董事會主席,並在引導公司戰略方向方面發揮了重要作用,現轉任首席獨立董事,成爲董事會的有效領導者,確保董事會的議程能夠成功履行其職責。在這一角色中,Branden將繼續與董事會主席一起,監督董事會履行其職責、公司治理、戰略倡議和Lifeist的業務,同時爲公司的管理層提供有價值的獨立監督。

These appointments reflect Lifeist's commitment to a strong governance framework, ensuring that both executive leadership and independent oversight remain robust as the Company continues to focus on growth in its health and wellness portfolio. In addition, the Board's Compensation Committee has initiated a comprehensive review of board compensation to ensure it aligns with the Company's evolving structure, size, and strategic direction. This review underscores the directors' continued commitment to the long-term success of the Company and their willingness to prioritize the organization's needs over personal gain, as demonstrated throughout their tenure.

這些任命反映了Lifeist對強有力治理框架的承諾,確保隨着公司繼續專注於其健康和健康產品組合的增長,執行領導和獨立監督保持強健。此外,董事會的薪酬委員會已經啓動了對董事薪酬的全面審查,以確保其與公司的不斷演變的結構、規模和戰略方向保持一致。此審查強調了董事們對公司長期成功的持續承諾,以及他們願意優先考慮組織需求而非個人利益的表現,這一點在他們的任期中已經得到了證明。

Lifeist also reports, as required by the TSXV, in connection with the Consulting Agreement originally announced on June 30, 2023, renewed effective August 1, 2024, and as terminated on October 31, 2024, entered into by the Company with Singular Narrative Management Ltd. ("Singular") for the provision of strategic business consulting, product development, and brand marketing services to the Company as well as other services that do not include investor relations or promotional activities, that it has issued an aggregate of 747,305 common shares and 747,305 common share purchase warrants to acquire up to 747,305 common shares as payment to Singular of the monthly fee of $20,000 for services provided in the months of August, September and October 2024, calculated in accordance with the amended Consulting Agreement. The common shares were issued at deemed prices per share ranging from $0.06-$0.09. The warrants have an exercise price ranging from $0.06-$0.10 per share and expire 5 years from their respective date of issuance.

Lifeist還報告稱,按照TSXV的要求,關於最初於2023年6月30日宣佈的諮詢協議,該協議於2024年8月1日生效,並於2024年10月31日終止,公司與Singular Narrative Management Ltd.("Singular")簽訂,以向公司提供戰略業務諮詢、產品開發和品牌營銷服務,以及其他不包括投資者關係或推廣活動的服務,已向Singular發放了總計747,305股普通股和747,305份可購買747,305股普通股的Warrants,作爲2024年8月、9月和10月提供服務的每月費用$20,000的支付,按修訂後的諮詢協議計算。普通股的發行價格按每股從$0.06-$0.09進行評估。Warrants的行使價格從每股$0.06-$0.10不等,且從各自發行之日起5年內到期。

About Lifeist Wellness Inc.

關於Lifeist Wellness Inc.

Sitting at the forefront of the post-pandemic wellness revolution, Lifeist leverages advancements in science and technology to develop innovative products that support human wellness and transform lives. Lifeist's key asset is its U.S. biosciences subsidiary Mikra Cellular Sciences Inc. ("Mikra"), a biosciences and consumer wellness company focused on developing and selling innovative wellness products.

站在後疫情時代健康革命的最前沿,Lifeist 利用科學和科技的進步開發創新產品,以支持人類健康並改變生活。Lifeist 的關鍵資產是其美國生物科學子公司 Mikra Cellular Sciences Inc.("Mikra"),這是一家專注於開發和銷售創新健康產品的生物科學和消費健康公司。

Information on Lifeist and its businesses can be accessed through the links below:

有關Lifeist及其業務的信息可以通過以下鏈接訪問:

Contact:
Andrea Judge
CEO
Lifeist Wellness Inc.
Ph: 888-291-8311
Email: ir@lifeist.com

聯繫方式:
安德烈亞·賈dge
首席執行官
Lifeist Wellness Inc.
電話:888-291-8311
電子郵件: ir@lifeist.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.

TSX創業公司交易所和其監管服務提供商(如TSX創業公司政策中所定義的那樣)均不對本公告的充分性或準確性負責並且未以任何方式批准或否決本新聞稿的內容。

Source: Lifeist Wellness Inc.

來源:Lifeist Wellness Inc.


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論